aspirin has been researched along with arginyl-glycyl-aspartyl-valine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, J; Peng, S; Wang, C; Zhao, M | 1 |
Cui, G; Peng, S; Zhang, J; Zhao, M | 1 |
Gao, W; Jin, S; Liu, J; Peng, S; Wang, Y; Wu, J; Zhao, M; Zhao, S; Zhu, H | 1 |
3 other study(ies) available for aspirin and arginyl-glycyl-aspartyl-valine
Article | Year |
---|---|
Synthesis and bioactivities of nitronyl nitroxide and RGD containing pseudopeptides.
Topics: Amino Acid Sequence; Nitrogen Oxides; Oligopeptides; Structure-Activity Relationship | 2003 |
A class of novel nitronyl nitroxide labeling basic and acidic amino acids: synthesis, application for preparing ESR optionally labeling peptides, and bioactivity investigations.
Topics: Amino Acids, Acidic; Amino Acids, Basic; Animals; Cytoprotection; Electron Spin Resonance Spectroscopy; Fibrinolytic Agents; Free Radicals; Molecular Structure; Nitrogen Oxides; PC12 Cells; Peptides; Platelet Aggregation; Rats; Structure-Activity Relationship; Vasodilation | 2008 |
Nanosized aspirin-Arg-Gly-Asp-Val: delivery of aspirin to thrombus by the target carrier Arg-Gly-Asp-Val tetrapeptide.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 1; Dose-Response Relationship, Drug; Fibrinolytic Agents; Male; Nanocapsules; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Rats, Wistar; Thrombosis; Treatment Outcome | 2013 |